CN101538516A - Maca grape wine and preparation method thereof - Google Patents
Maca grape wine and preparation method thereof Download PDFInfo
- Publication number
- CN101538516A CN101538516A CN200910009343A CN200910009343A CN101538516A CN 101538516 A CN101538516 A CN 101538516A CN 200910009343 A CN200910009343 A CN 200910009343A CN 200910009343 A CN200910009343 A CN 200910009343A CN 101538516 A CN101538516 A CN 101538516A
- Authority
- CN
- China
- Prior art keywords
- preparation
- pulp
- maca
- wine
- agate coffee
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009754 Vitis X bourquina Nutrition 0.000 title claims abstract description 28
- 235000012333 Vitis X labruscana Nutrition 0.000 title claims abstract description 28
- 235000014787 Vitis vinifera Nutrition 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 240000000759 Lepidium meyenii Species 0.000 title abstract description 11
- 235000000421 Lepidium meyenii Nutrition 0.000 title abstract description 11
- 235000012902 lepidium meyenii Nutrition 0.000 title abstract description 11
- 240000006365 Vitis vinifera Species 0.000 title 1
- 241000219095 Vitis Species 0.000 claims abstract description 30
- 238000000855 fermentation Methods 0.000 claims abstract description 17
- 230000004151 fermentation Effects 0.000 claims abstract description 17
- 238000009923 sugaring Methods 0.000 claims abstract description 15
- 238000011282 treatment Methods 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 4
- 238000000926 separation method Methods 0.000 claims abstract description 3
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 241001593968 Vitis palmata Species 0.000 claims abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 51
- 235000016213 coffee Nutrition 0.000 claims description 46
- 235000013353 coffee beverage Nutrition 0.000 claims description 46
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 16
- 235000000346 sugar Nutrition 0.000 claims description 14
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 238000007710 freezing Methods 0.000 claims description 10
- 230000008014 freezing Effects 0.000 claims description 10
- 239000002516 radical scavenger Substances 0.000 claims description 10
- 239000005720 sucrose Substances 0.000 claims description 10
- 230000032683 aging Effects 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 8
- 239000007789 gas Substances 0.000 claims description 8
- 238000013467 fragmentation Methods 0.000 claims description 7
- 238000006062 fragmentation reaction Methods 0.000 claims description 7
- 230000008676 import Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 235000009392 Vitis Nutrition 0.000 claims description 3
- 239000000440 bentonite Substances 0.000 claims description 3
- 229910000278 bentonite Inorganic materials 0.000 claims description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000011146 sterile filtration Methods 0.000 claims description 3
- 238000007669 thermal treatment Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 235000019674 grape juice Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 241000219094 Vitaceae Species 0.000 abstract 6
- 235000021021 grapes Nutrition 0.000 abstract 6
- 230000009982 effect on human Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 240000007154 Coffea arabica Species 0.000 description 36
- 230000000694 effects Effects 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000036299 sexual function Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000002124 endocrine Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 201000001880 Sexual dysfunction Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 235000002378 plant sterols Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 231100000872 sexual dysfunction Toxicity 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036624 brainpower Effects 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000008373 coffee flavor Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Alcoholic Beverages (AREA)
Abstract
The invention relates to a preparation method of Maca grape wine, belonging to the field of wine products. The preparation method is as follows: a fruit pulp which is recoverably prepared by adding quintuple water to fresh Maca or dry Maca and a fruit pulp which is prepared by removing stems of fresh grapes (white grapes or red grapes) and then crushing the fresh grapes (white grapes or red grapes) are mixed according to volume proportion by weight percent: 1-35 of Maca and 99-65 of grapes, and the Maca grape wine is obtained by steps such as temperature control fermentation, sugaring, reladling separation, purification treatment, cryothermal treatment or heat treatment, filtering, sterilization, and the like, wherein during the temperature control fermentation process, the temperature is controlled between 28 DEG C and 30 DEG C (the temperature has to be controlled between 18 DEG C and 20 DEG C when the Maca grape wine is mixed with white grape juice to ferment). The Maca grape wine sufficiently retains the double nutrition and heath care ingredients of the Maca and the grapes, thereby having good health-care and medical effect; and in addition, the Maca grape wine has smooth and soft mouthfeel and pleasant bouquet and has no ingredients which generate side effect on human bodies after being detected.
Description
(1) technical field
The present invention relates to a kind of vinous liquor preparation method, belong to the wine product field.
(2) background technology
The international title maca of agate coffee----(formal name used at school LEPIDJUM MEYENII WALP) belongs to Cruciferae separate row Vegetable spp plant.Originate in Peru, be called Peru's genseng or North America genseng by people.Now by the success of Yunnan Province of China Lijing introduction of plant.It grows in height above sea level 3500-4500 rice plateau, the temperature difference big (day and night temperature 30-50 ℃), illumination fully, ultraviolet ray strong, air rarefaction, oxygen shortages, high and cold low temperature, often have in the environment that frost, wind are moistening greatly, rainwater abundant, fertile, the husky property of soil property is loosened.
The nutritive ingredient of agate coffee is very abundant, and protein content is higher than other root class plant, and contains the indispensable VITAMIN of the multiple mankind, mineral substance, amino acid.Its main pharmacology health-care effect is embodied in:
1, physical strength reinforcing, antifatigue.The agate coffee contains rich in amino acid, and rational in infrastructure, and its a high proportion of bad amino acid can improve tiring of plant protein, has the nutritional fortification effect; Contained branched-chain amino acid (leucine, propylhomoserin, Isoleucine) plays an important role at elimination mobility central nerve fatigue and human body fatigue.Contained mineral substance zinc can be regulated the neuro-endocrinology hormone level, strengthens human body anti-fatigue ability at high temperature; 100 gram agate coffees contain 77 milligrams taurine, can promote the digestion of human body to lipid, strengthen myocardial contraction.Contained vitamin B1, B2, linolic acid, linolenic acid, nutritional activities compositions such as sterol can promote each tissue of human body by blood circulation picked-up raw material, strengthen metabolism, guarantee the constant relatively of the inner physico-chemical property of body tissue.
2, endocrine regulation delays senility.The multiple alkaloid component that the agate coffee is contained all has effect to the male still endocrine regulation of female hormone.Contained sterol and saponin(e are as the precursor of multiple hormone, and contained meson oil glycosides and isothiocyanic acid benzyl fat also play a role to endocrine regulation, keep the elderly's endocrine system balance and stability.
3, sexual function improving improves fertility.Agate coffee alkene that the agate coffee contains and agate coffee acid amides two kind of plant active substances all have obvious effect to improving men and women's sexual function, be referred to as by some developed countries " natural vigour ", contained algae resin acid, arginine can effectively improve the quality and the mobility of sperm.Contained phenylalanine,
The precursor substance of delivery signal helps to improve the character amount in the synthetic just sexual function central nervous system of propylhomoserin and Histidine.Agate coffee alkene and agate coffee acid amides enter the hypothalamus of brain with blood after by human consumption, sexual gland systems such as pituitary gland and ovary and testis, and the hormonal secretion of modulability keeps human body natural's excretory sexual hormoue and returns to normal level.
4, ease off the pressure, alleviate anxiety.Agate coffee extract can directly act on pituitary gland, human body is had adapt to the former state effect, and counter pressure alleviates intense strain, promotes brain power, and it is clear to keep brain, improves insomnia, eliminates tired outly, keeps good muscle power that positive effect is all arranged.
5, the inhibition canceration is antitumor.Contained benzyl meson oil glycosides of agate coffee and the distinctive bioactive ingredients of benzyl isothiocyanic acid are a kind of antimitotic agents, and be to chemocarcinogenesis (comprising lung cancer, bladder cancer, esophagus cancer, cancer of the stomach, intestinal cancer, thyroid carcinoma, leukemia etc.), all inhibited.The contained distinctive plant sterol activeconstituents of agate coffee, teas phenol etc. are also confirmed it is to suppress the antineoplastic active substance of canceration by medical circle.Through scientist's experiment confirm, the effective constituent of edible agate coffee extract, have the effect that strengthens macrophage phagocytic function and improve NK cell activity lipid acid, health nutrient compositions such as contained unsaturated fatty acids, vitamins C, food fibre also can play anticancer auxiliary function effectively.
6, other pharmacology health-care effect of agate coffee
Mineral substance such as A. high-load iron, calcium and rich in protein, amino acid have significant therapeutic effect to anaemia.
B. its abundant plant sterol and its derivative can reduce coronary atherosclerotic heart disease, benign prostatauxe, blood fat reducing effectively significantly.
C. its taurine that contains has anti-insane pain, hypotensive, adjusting irregular pulse, and cardiac function enhancing improves effects such as retinal function and adjusting osmotic pressure.
D. its contained steroid and adrenotrophin class material can be used for the treatment of respiratory system diseases such as asthma.
E. but agate coffee compound product balance human body skin pigment is eliminated the fibrosis scar tissue, recovers beautiful smooth making a breakthrough property of healthy skin effect.
F. its contained active substance and rich nutrient contents can make the human body brain alleviate anoxic, enhance metabolism, and keep resourceful, prevent alcoholism.
(3) summary of the invention
[problem that will solve]
The purpose of this invention is to provide a kind of vinous liquor that human body is highly profitable, the preparation method of this wine is provided simultaneously.
[technical scheme]
Through development repeatedly, the method that has obtained preparing vinous liquor that the inventor is surprised.
Adopt the dry type preparation of wine, with bright agate coffee or add 5 times water recovery with dried agate coffee and make pulp, be prepared from the mixed fermentation of fresh grape pulp.Can produce dry type, alcoholic strength is 12%V/V, ± 1%V/V; Pol is≤4g/L, half-dry type, and pol is 4.1g/L-12.0g/L, semi-sweet, and pol is 12.1g/L-45.0g/L, sweet type, and pol is＞45.0g/L.
Ingredient requirement
The agate coffee should be that the Yunnan Lijing produces sophisticated agate coffee fruit, and grape is sophisticated grape, and the ratio (by volume) of agate coffee pulp and fresh grape pulp is: agate coffee 1%-35%; Grape 99%-65%.
Making method is as follows:
1, bright agate coffee is cleaned, pulp is made in fragmentation, maybe will add 5 times of water through the dried agate coffee that cleans and soak recovery in open container, makes pulp with crusher in crushing again, thereafter, pulp is imported in the vertical digester.
2, grape destemming fragmentation.With the fragmentation of grape destemming, then, Sucus Vitis viniferae is input to mixed fermentation in the vertical digester that agate coffee pulp is housed with the destemming crusher.Therebetween should be along with the input of grape pulp adds sulfurous gas, treat that grape pulp and agate coffee pulp reach the ratio of setting after, stop to import the grape pulp, adding polygalacturonase and yeast.At this moment, measure two kinds of mixed sugar degrees of pulp in the jar, acid content is as being in harmonious proportion later on and with the foundation of sucrose.
3, temperature controlled fermentation.Temperature should be controlled at 28 ℃ to 30 ℃ (being controlled at 18 ℃ to 20 ℃ with Fructus Vins pulp mixed fermentation temperature), the too high or too low effect that all can influence fermentation.
4, sugaring opportunity.When the sugar-fermenting of pulp is consumed to 1/2 or 3/5, add sucrose, total sugar degree in the pulp is reached be higher than 200g/L, preferred 204g/L.(desired sugars g/L deducts the sugared g/L of actual measurement to the sugaring calculation formula, multiply by tonnage, equals sugaring kilogram number.During sugaring, rise container, the sucrose stirring is melted, pour in the jar by last hand-hole again with the pulp of emitting in the jar with 500-1000.
5, tank switching separates.Pulp after sugaring makes total reducing sugar drop to 4g/L when following through fermentation once more, adjusts in the wine juice free sulfurous gas to 30-50mg/L, tank switching separation after 7 days.Pour in down a chimney method: open the second joint door.Emit wine juice until cutout.Then.Open bottom joint door, control out residual wine juice.Whole juice, the control juice process of putting forbids to stir jar endothelium slag and wine mud.
6, purifying treatment.Employing adds scavenging agent (gelatin of import, bentonite) in wine juice method purifies.Should make sample in the laboratory before purifying, determine the scavenging agent optimum addition.Add scavenging agent after 15 days, separate with centrifugal disc formula diatomite filter.At last, the wine juice after separating is added full wine jar, after adjusting every index and reaching the GB/T15037-2006 operative norm, enter the ageing stage.
7, freezing treatment.The ageing of wine juice finishes, and forms former wine, adopts the mechanical refrigeration method, and wine juice is placed refrigerated cylinder, keeps the wine temperature about-4.5 ℃ to-5.0 ℃ one weeks.When freezing, the refrigerated cylinder sealing, and fill up sulfurous gas, note anti-oxygen.
8, thermal treatment.When preparation half-dry type, semi-sweet, sweet type vinous liquor, with the wine juice of sucrose after with ageing adjust to meet the pol that dissimilar (half-dry type, semi-sweet, sweet types) adapt after, placed under 73 ℃ of states thermally-stabilised 2 hours then 1-2 month.
9, filter bottling.With the wine juice after freezing, to adopt five road filtration methods to take advantage of the cold winestone that carries out and separate, plug is bottled, is beaten in Sterile Filtration and smart filter thereafter.To carry out the bus sterilization through thermally-stabilised cooled again wine juice, filter and smart filter, bottle, beat plug thereafter.
[beneficial effect]
Vinous liquor of the present invention has following characteristics:
Finished wine is as clear as crystal.Vinosity is mellow and full agreeable to the taste, and is clearly pleasant, do not have obvious agate coffee flavor, and acidity is medium, and fragrant field width is wealthy.
This product has fully kept the double nutrition and the health-care components of agate coffee and grape, and good health care and medical functions are arranged.Its function is:
1, endocrine regulation is mended intensive culture the moon.Drink in right amount for a long time, can make the people energetic, face gloss reaches body-building, delays senility, and makes the purpose of people's longevity.
2, sexual function improving improves life quality, increases Fertility, and the infertility that certain reason is caused has good medical functions.
3, can relax the muscles and stimulate the blood circulation, vessel softening, blood fat reducing alleviates the blood sugar degree, is product on prevention of brain thrombus and the heart trouble.
4, certain inhibition canceration, antitumor effect are arranged.
But respiratory system diseases such as 5 assisting therapy asthmas.
(4) description of drawings
Fig. 1: vinous liquor process flow sheet.
(5) embodiment
Following examples are used to illustrate the present invention, but are not used for limiting the scope of the invention.
Embodiment 1
Agate coffee and grape ratio are: agate coffee 5% grape 95% maybe adds dried agate coffee 5 times of water with bright agate coffee and restores, and agate coffee powdered is made in fragmentation, makes pulp.Pulp is imported in the vertical digester.Thereafter, Sucus Vitis viniferae is input to mixed fermentation in the vertical digester that agate coffee pulp is housed.Therebetween should be along with the input of grape pulp adds sulfurous gas, treat that grape pulp and agate coffee pulp reach the ratio of setting after, stop to import grape juice, adding polygalacturonase and yeast.At this moment, measure two kinds of mixed sugar degrees of pulp in the jar, acid content.
Temperature controlled fermentation, temperature should be controlled at 28 ℃ to 30 ℃ (with the mixed fermentation of Fructus Vins pulp, temperature should be controlled at 18 ℃ to 20 ℃), the too high or too low effect that all can influence fermentation.When the sugar-fermenting of pulp is consumed to 1/2 or 3/5, add sucrose, make the total sugar degree in the pulp reach 204g L.(desired sugars g/L deducts the sugared g/L of actual measurement to the sugaring calculation formula, multiply by tonnage, equals sugaring kilogram number.During sugaring, rise container, the sucrose stirring is melted, again by in the last hand-hole input jar with the pulp of emitting in the jar with 500-1000.
Pulp after sugaring is through fermentation once more, makes total reducing sugar drop to 4g/L or when following, adjusts that free sulfurous gas is to 30-50mg/L in the wine juice, and tank switching separates after 7 days.Pour in down a chimney method: open the second joint door.Emit wine juice until cutout.Then.Open bottom joint door, vacate residual wine juice.Whole juice, the control juice process of putting forbids to stir jar endothelium slag and wine mud.
Employing adds scavenging agent (gelatin of import, bentonite) in wine juice method purifies.Should make sample in the laboratory before purifying, determine the scavenging agent optimum addition.Add scavenging agent after 15 days, separate with centrifugal disc formula diatomite filter.At last, the wine juice after separating is added full wine jar, after adjusting every index and reaching the GB/T15037-2006 operative norm, enter the ageing stage.
The ageing of wine juice finishes, and forms former wine, adopts the mechanical refrigeration method, and wine juice is placed refrigerated cylinder, keeps the wine temperature about-4.5 ℃ to-5.0 ℃ one weeks.When freezing, the refrigerated cylinder sealing, and fill up sulfurous gas, note anti-oxygen.With the wine juice after freezing, to adopt five road filtration methods to take advantage of the cold winestone that carries out and separate, plug is bottled, is beaten in Sterile Filtration and smart filter thereafter.
Embodiment 2
The ratio that adopts is: agate coffee 10%; Grape 90%.Other conditions are identical with embodiment 1.
Embodiment 3
The ratio that adopts is: agate coffee 20%; Grape 80%.Other conditions are identical with embodiment 1.
Embodiment 4
The ratio that adopts is: agate coffee 35%; Grape 65%.Other conditions are identical with embodiment 1.
Embodiment 5
Adopt embodiment 1-5 preparation method, by vinous liquor being deployed into half-dry type (sugar degree 4.1g/L-12.0g/L) with sucrose, semi-sweet (sugar degree 12.1g/L-45.0g/L), sweet type (＞45.0g/L).Placed 1-2 month the deployed back of half-dry type, semi-sweet, sweet type vinous liquor, under 73 ℃ of states thermally-stabilised 2 hours then.Plug is played in cooling, the bottling of bus disinfection filtering, forms former wine.
The vinous liquor mouthfeel that obtains of embodiment is good from the above mentioned, and the composition that human body is not had side effects is drunk through hundreds of people after testing, proves HUMAN HEALTH of great advantage really.
Result of use is as follows:
| Use object | Number | Use fate | Efficient | Use back effect explanation |
| Tired lassitude | 1000 | 30 | 87.5 | Regain one's strength, Ginseng Extract, recovery youth |
| Stress is big | 230 | 30 | 76.4 | Eliminated pressure, not dejected |
| Female acyesis | 330 | 60 | 74.7 | Strengthened the normal ovulation function of women |
| Menstrual period are irregular | 500 | 30 | 67.7 | Normal menstrual period, cycle stability have been recovered |
| The postmenopausal women syndromes | 340 | 30 | 69.5 | Alleviated menopausal symptoms and the qi and blood worry that has some setbacks |
| Lack sexual desire | 1120 | 30 | 95.6 | Young and middle-aged psychological need and desire have been recovered |
| Man's sperm deficiency | 200 | 60 | 65.0 | Man's sperm count increases, has strengthened Fertility |
| Impotence, early ageing | 470 | 30 | 65.4 | Regenerate virility, improved sexual function |
| Man's climacteric syndrome | 310 | 60 | 77.4 | The youthful vigor that keeps the male sex |
| Sexual dysfunction | 560 | 60 | 72.6 | Men and women's sexual dysfunction, sexual life harmony have been removed |
| Hypertension | 740 | 30 | 68.3 | Get well and normal blood pressure |
| Diabetes | 210 | 60 | 67.1 | Check obtains satisfied control |
| Rheumatosis | 310 | 60 | 85.0 | Ache and fatigue symptom disappears |
| Bronchitis | 130 | 60 | 74.6 | Cough and symptoms of asthma are improved |
| Richets | 120 | 60 | 62.5 | Removed the puzzlement of rickets |
| Anemia | 440 | 60 | 82.4 | Realization enrich blood regulating the qi flowing in the channels, strengthened blood circulation |
| Constipation | 230 | 30 | 61.7 | Remove constipation, normal defecation, get well |
Claims (12)
1, a kind of preparation method of vinous liquor, it is characterized in that bright agate coffee is maybe added dried agate coffee 5 times water to restore and to make pulp that pulp makes through the destemming fragmentation with new fresh grape ratio agate coffee 1%-35% by volume, grape 99%-65% mixes, through temperature controlled fermentation, sugaring, tank switching separation, purifying treatment, freezing treatment or thermal treatment, filtration, steps such as sterilization obtain vinous liquor.Temperature should be controlled at 28 ℃ to 30 ℃ (should be controlled at 18 ℃ to 20 ℃ with Fructus Vins juice mixed fermentation temperature) in the wherein said temperature controlled fermentation process.
2, the preparation method of vinous liquor as claimed in claim 1, wherein saidly bright agate coffee is maybe added dried agate coffee 5 times water restore and to make pulp, be through using import crusher in crushing powdered with the agate coffee, obtain agate coffee pulp, agate coffee percentage of damage is 100%, then pulp is input in the vertical digester.
3, the preparation method of vinous liquor as claimed in claim 1, the fragmentation of wherein said grape destemming, be with fresh grape (Fructus Vins or red grape), with the fragmentation of destemming crusher destemming, then pulp is input in the vertical digester that agate coffee pulp is housed and mixes (Fructus Vins is to mix with agate coffee pulp with Sucus Vitis viniferae being imported in the vertical digester after the squeezing machine squeezing) again.
4, the preparation method of vinous liquor as claimed in claim 1, wherein in said sugaring step: when the sugar-fermenting of pulp is consumed to 1/2 or 3/5, add sucrose, total sugar degree in the pulp is reached be higher than 200g/L, preferred 204g/L. sugaring method is: rise container with 500-1000, with the pulp of emitting in the jar sucrose stirring is melted, pour in the jar by last hand-hole again.
5, the preparation method of vinous liquor as claimed in claim 1, wherein after said sugaring step, the pulp after sugaring is through fermentation once more, makes total reducing sugar drop to 4g/L or when following, adjusts free sulfurous gas 30-50mg/L in the wine juice, and tank switching separates after 7 days.
6, the preparation method of vinous liquor as claimed in claim 1, wherein in said purifying treatment step, employing adds scavenging agent in wine juice method purifies, wherein, should make sample in the laboratory before purifying, determine the scavenging agent optimum addition, add scavenging agent after 15 days, after separating with centrifugal disc formula diatomite filter, adjust the index of wine, enter the ageing stage.
7, the preparation method of vinous liquor as claimed in claim 5 is gelatin, bentonite at said scavenging agent wherein.
8, the preparation method of vinous liquor as claimed in claim 5 wherein after the index of said adjustment wine is to reach the GB/T15037-2006 operative norm according to every index, enters the ageing stage.
9, the preparation method of vinous liquor as claimed in claim 1, wherein in said freezing treatment method be: the ageing of wine juice finishes, form former wine, adopt the mechanical refrigeration method, wine juice is placed refrigerated cylinder, keep the wine temperature about-4.5 ℃-5.0 ℃ weeks, when freezing, the refrigerated cylinder sealing, and fill up sulfurous gas, note anti-oxygen.
10, the preparation method of vinous liquor as claimed in claim 8 after freezing treatment finishes, with the wine juice after freezing, adopts five road filtration methods to take advantage of the cold winestone that carries out and separates, and plug is then bottled, beaten in Sterile Filtration and smart filter, obtains the finished product.
11, the preparation method of vinous liquor as claimed in claim 1, wherein said thermal treatment, be at preparation half-dry type, semi-sweet, by mode, the sugar degree of vinous liquor is adjusted to 4.1g/L-12.0g/L (half-dry type), 12.1g/L-45.0g/L (semi-sweet) during sweet type vinous liquor with sucrose;＞45g/L (sweet type) placed 1-2 month, and under 73 ℃ of states thermally-stabilised 2 hours then, through cooling, pasteurize, filtration and smart filter, plug was played in bottling thereafter again.
12, a kind of vinous liquor is characterized in that adopting the vinous liquor as any method preparation among the claim 1-11 can be dry type, half-dry type, semi-sweet, sweet type.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910009343A CN101538516A (en) | 2009-02-19 | 2009-02-19 | Maca grape wine and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910009343A CN101538516A (en) | 2009-02-19 | 2009-02-19 | Maca grape wine and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101538516A true CN101538516A (en) | 2009-09-23 |
Family
ID=41121907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910009343A Pending CN101538516A (en) | 2009-02-19 | 2009-02-19 | Maca grape wine and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101538516A (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102229872A (en) * | 2010-08-11 | 2011-11-02 | 王国军 | Fermented wine suitable for women and brewing method thereof |
| CN102994346A (en) * | 2012-12-01 | 2013-03-27 | 王百鸣 | Base stock for preparing MACA wine |
| CN103468472A (en) * | 2013-09-23 | 2013-12-25 | 李家民 | Maca fruit wine and preparation method thereof |
| CN103468507A (en) * | 2013-09-09 | 2013-12-25 | 江苏恒顺醋业股份有限公司 | Maca yellow rice wine and preparation method thereof |
| CN103589555A (en) * | 2013-10-21 | 2014-02-19 | 烟台金色庄园玛卡酒业有限公司 | Maca brandy |
| CN103602542A (en) * | 2013-10-21 | 2014-02-26 | 烟台金色庄园玛卡酒业有限公司 | Maca whisky |
| CN103602571A (en) * | 2013-10-21 | 2014-02-26 | 烟台金色庄园玛卡酒业有限公司 | Maka wine |
| CN103710197A (en) * | 2013-11-25 | 2014-04-09 | 牛建伟 | Preparation method for maca grape wine |
| CN103756831A (en) * | 2013-10-21 | 2014-04-30 | 烟台金色庄园玛卡酒业有限公司 | Maca-ipomoea batatas wine |
| CN104673570A (en) * | 2015-02-05 | 2015-06-03 | 栗阳 | Health wine |
| CN104789419A (en) * | 2015-04-22 | 2015-07-22 | 李桂斌 | Maca wine and production method thereof |
| CN104962412A (en) * | 2015-06-08 | 2015-10-07 | 齐鲁工业大学 | Making method for Maca wine |
| CN105112191A (en) * | 2015-08-26 | 2015-12-02 | 甘肃滨河食品工业（集团）有限责任公司 | Method for manufacturing maca red wine |
| CN106148060A (en) * | 2015-04-02 | 2016-11-23 | 烟台东方华夏葡萄酒有限公司 | A kind of preparation method of Lepidinm meyenii Walp Flos Rosae Rugosae extra dry white wine |
| CN106148061A (en) * | 2015-04-02 | 2016-11-23 | 烟台东方华夏葡萄酒有限公司 | A kind of preparation method of Lepidinm meyenii Walp Flos Rosae Rugosae extra dry red wine |
| CN106987492A (en) * | 2017-06-09 | 2017-07-28 | 袁学军 | A kind of fruit wine and preparation method thereof |
-
2009
- 2009-02-19 CN CN200910009343A patent/CN101538516A/en active Pending
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102229872B (en) * | 2010-08-11 | 2013-05-01 | 王国军 | Fermented wine suitable for women and brewing method thereof |
| CN102229872A (en) * | 2010-08-11 | 2011-11-02 | 王国军 | Fermented wine suitable for women and brewing method thereof |
| CN102994346A (en) * | 2012-12-01 | 2013-03-27 | 王百鸣 | Base stock for preparing MACA wine |
| CN103468507A (en) * | 2013-09-09 | 2013-12-25 | 江苏恒顺醋业股份有限公司 | Maca yellow rice wine and preparation method thereof |
| CN103468472B (en) * | 2013-09-23 | 2014-12-31 | 李家民 | Maca fruit wine and preparation method thereof |
| CN103468472A (en) * | 2013-09-23 | 2013-12-25 | 李家民 | Maca fruit wine and preparation method thereof |
| CN103589555A (en) * | 2013-10-21 | 2014-02-19 | 烟台金色庄园玛卡酒业有限公司 | Maca brandy |
| CN103756831B (en) * | 2013-10-21 | 2015-06-17 | 玛卡龙酒业有限公司 | Maca-ipomoea batatas wine |
| CN103602571B (en) * | 2013-10-21 | 2015-06-17 | 玛卡龙酒业有限公司 | Maka wine |
| CN103756831A (en) * | 2013-10-21 | 2014-04-30 | 烟台金色庄园玛卡酒业有限公司 | Maca-ipomoea batatas wine |
| CN103602542A (en) * | 2013-10-21 | 2014-02-26 | 烟台金色庄园玛卡酒业有限公司 | Maca whisky |
| CN103602542B (en) * | 2013-10-21 | 2015-06-03 | 玛卡龙酒业有限公司 | Maca whisky |
| CN103602571A (en) * | 2013-10-21 | 2014-02-26 | 烟台金色庄园玛卡酒业有限公司 | Maka wine |
| CN103710197A (en) * | 2013-11-25 | 2014-04-09 | 牛建伟 | Preparation method for maca grape wine |
| CN103710197B (en) * | 2013-11-25 | 2015-08-05 | 牛建伟 | A kind of agate card preparation of wine |
| CN104673570A (en) * | 2015-02-05 | 2015-06-03 | 栗阳 | Health wine |
| CN106148060A (en) * | 2015-04-02 | 2016-11-23 | 烟台东方华夏葡萄酒有限公司 | A kind of preparation method of Lepidinm meyenii Walp Flos Rosae Rugosae extra dry white wine |
| CN106148061A (en) * | 2015-04-02 | 2016-11-23 | 烟台东方华夏葡萄酒有限公司 | A kind of preparation method of Lepidinm meyenii Walp Flos Rosae Rugosae extra dry red wine |
| CN104789419A (en) * | 2015-04-22 | 2015-07-22 | 李桂斌 | Maca wine and production method thereof |
| CN104962412A (en) * | 2015-06-08 | 2015-10-07 | 齐鲁工业大学 | Making method for Maca wine |
| CN105112191A (en) * | 2015-08-26 | 2015-12-02 | 甘肃滨河食品工业（集团）有限责任公司 | Method for manufacturing maca red wine |
| CN106987492A (en) * | 2017-06-09 | 2017-07-28 | 袁学军 | A kind of fruit wine and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101538516A (en) | Maca grape wine and preparation method thereof | |
| CN101654640A (en) | Maca wine and preparation method thereof | |
| CN101245307B (en) | Melon and fruit vinegar and manufacture method thereof | |
| CN101508945A (en) | Fermented vinous liquor and preparation method thereof | |
| CN104544395B (en) | A kind of plant fruit fermenation raw liquid | |
| CN100519730C (en) | Process of making aromatic vinegar by using bananas | |
| CN101705173B (en) | Maca brandy and preparation method thereof | |
| CN101285023A (en) | Red raspberry health wine and brewing process thereof | |
| CN103960729A (en) | Low-sugar black garlic flower beverage and preparation method thereof | |
| CN102960789A (en) | Isatis root and red date concentrated slurry product | |
| CN104256783A (en) | Chinese yam, Chinese date and barbary wolfberry fruit beverage and preparation method thereof | |
| CN105918742A (en) | Beverage capable of promoting sleep, expelling toxins, and nourishing skin | |
| CN101869145B (en) | Weight reducing milk tea and preparation method thereof | |
| CN1935036A (en) | Aloe-sea buckthorn nutrient health drink and its prepairng method | |
| CN105969592A (en) | Clausena lansium/passion fruit wine | |
| CN101560455A (en) | Method for producing nutritious and health-protection tea liquor | |
| CN103642623B (en) | A kind of Composite fermentation type purslane health-care wine and production technology thereof | |
| CN108420064A (en) | Preparation method of rose and persimmon composite enzyme | |
| CN105062773A (en) | Compound fermented health drink containing maca and production process of health drink | |
| CN1733885B (en) | Broomrape dry red wine and its preparation method | |
| CN101955874B (en) | Method for brewing bitter almond liqueur | |
| CN110184157A (en) | Deer blood, alcoholic drink mixed with fruit juice of rhizoma polygonati and preparation method thereof is added by wine base of mulberries fermented wine | |
| CN103710197A (en) | Preparation method for maca grape wine | |
| CN103798902A (en) | Preparation method of cynomorium songaricum and medlar vinegar beverage | |
| CN104419626A (en) | Water lily flower honey wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LIU YOUXIAN MA YUXIANG PENG XINQUAN Effective date: 20120331 Owner name: BEIJING QILI MAKA TECHNOLOGY DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: YANG YONGWU Effective date: 20120331 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 100011 DONGCHENG, BEIJING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120331 Address after: 100011 Beijing, Dongcheng District Anwai No. 11 Building 1 501 Washington Gardens Applicant after: Beijing Qilimaka Technology Development Co., Ltd. Address before: 100083 building four, East Wang Zhuang, Beijing, Haidian District 1107 Applicant before: Yang Yongwu Co-applicant before: Liu Youxian Co-applicant before: Ma Yuxiang Co-applicant before: Peng Xinquan |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090923 |